Sep 28 close
Cooper Companies has faced pressure this week from activist investor Jana Partners, which is pushing for the CEO and board chair to be replaced and for parts of CooperVision and CooperSurgical to be explored for sale, following the stock's decline and concerns over inventory management and capital allocation. Separately, the company opened "The Vision Centre," a global hub in Southampton, England, unifying research, pilot manufacturing and clinical expertise to accelerate contact lens development for CooperVision. Multiple law firms, including Rosen, Pomerantz and Kirby McInerney, have also announced investigations into potential securities claims tied to the prior quarterly results and guidance.
COO closed at $56.57, up 2.1% on the day, but remains well below both its 50-day average of $68.08 and 200-day average of $71.87, with the shorter average sitting under the longer one. The GekkoIndex reads 64.1, placing the stock in the Accumulation zone, down 7 points over five days. Price sits 6.6% below the Gekko Fair Value of $60.55.
Cooper's next earnings report is set for 3 December 2026, 65 days out, beyond a typical 20-trading-day holding window. Over the last 90 days there were 5 insider purchases totaling $1,880,109, and over the last 30 days 2 unusual options signals were recorded, with call premium of $819,890 against put premium of $398,699. Seasonally, the next 20 trading days have averaged -0.4% over 5 years, rising in 1 of those years.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Cooper Companies scores 4 supportive, 0 mixed and 2 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive0 mixed2 headwinds
Below 50 and 200-day
Close $56.57 is below the 50-day ($68.08) and 200-day ($71.87) averages, and the 50-day is below the 200-day.
See the chart64.1, Accumulation
Reading 64.1 is in the Accumulation zone.
See the GekkoIndex6.6% below
Price is 6.6% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 5 open-market insider purchases. Last 30 days: 2 unusual options signals.
See smart moneyReports in 65 days
Next report Dec 3, 2026, 65 days away — outside a typical 20-trading-day hold.
See earnings−0.4% on average
From this point in the calendar, the next 20 trading days averaged −0.4% over 5 years, rising in 1 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Cooper Companies closed at $56.57 on Sep 28, 2026, −15.4% over the past year, inside a 52-week range of $51.01 to $89.83.
Use the left and right arrow keys to read daily values.
Put COO on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Cooper Companies makes and sells medical devices through two separate arms. One side of the business, focused on contact lenses, produces spherical lenses for standard nearsightedness and farsightedness along with more specialized designs for astigmatism, presbyopia, myopia control, and dry or tired eyes. These vision products reach wearers across the Americas, Europe, the Middle East, Africa and Asia Pacific.
The other arm concentrates on women's and family health, supplying hospitals, clinics and patients with surgical instruments, contraceptives, and fertility-related services. Its catalog includes the PARAGARD intrauterine device, along with uterine manipulators, retractors and closure devices used in surgical and office settings. It also supports fertility treatment through consumables, lab equipment, embryo handling services and preimplantation genetic screening.
Cooper Companies was founded in 1958 and is headquartered in San Ramon, California. Its shares are listed on the NASDAQ under the ticker COO.
Cooper Companies’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 64.1, in the Accumulation zone, down 7 points over five sessions.
Down 7 points over five sessions, from the Buying zone.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 81 | +0.2% | +1.6% | ||
| Accumulation (current zone) | 222 | −0.4% | +0.2% | ||
| Neutral | 339 | −0.4% | −2.3% | ||
| Distribution | 29 | 0.0% | −0.9% | ||
| Selling | 1 | Too few readings yet | |||
Average COO share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Cooper Companies trades 6.6% below Gekko Fair Value of $60.55, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Cooper Companies shares are worth, recalculated every trading day.
$60.55
Gekko Fair Value, Sep 26, 2026
6.6% Undervalued
Insiders filed 5 open-market purchases in Cooper Companies worth $1.88M, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$1.88Min 5 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 17 | Kurzius Lawrence Erik director | Purchase | $549K |
| Sep 15 | Rosebrough Walter M Jr director | Purchase | $379K |
| Sep 15 | Rosebrough Walter M Jr director | Purchase | $163K |
| Sep 15 | Kurzius Lawrence Erik director | Purchase | $539K |
| Sep 15 | Keel Paul A director | Purchase | $250K |
From Form 4 filings, dated to when each was filed.
No trades in COO were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Cooper Companies has been buying back its own shares.
From company filings.
2signals, 67% of the flagged premium in calls.
Latest: Bullish flow on Sep 19, $328K in unusual premium.
0of the funds Gekko tracks hold COO.
Cooper Companies reports on Dec 3, 2026, after the close (65 days away), and beat the EPS estimate in 8 of its last 8 reports.
Dec 3, 2026
Expected after the close, 65 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Sep 9, 2026 | $1.15 est $1.12 | $1.07B est $1.10B | −20.0% |
| Jun 4, 2026 | $1.21 est $1.10 | $1.08B est $1.05B | +11.6% |
| Mar 5, 2026 | $1.10 est $1.03 | $1.02B est $1.02B | −6.6% |
| Dec 4, 2025 | $1.15 est $1.11 | $1.07B est $1.06B | +7.1% |
| Aug 27, 2025 | $1.10 est $1.07 | $1.06B est $1.06B | −12.3% |
| May 29, 2025 | $0.96 est $0.93 | $1.00B est $995.3M | −14.8% |
| Mar 6, 2025 | $0.92 est $0.91 | $964.7M est $978.1M | −6.9% |
| Dec 5, 2024 | $1.04 est $1.00 | $1.02B est $1.03B | −6.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Cooper Companies is $66.21, +17.0% from the last close, from 13 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 13 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 13 | Stifel Nicolaus | $70 | +23.7% |
| Sep 12 | William Blair | — | — |
| Sep 11 | Mizuho Securities | $75 | +32.6% |
| Sep 11 | Citi | $60 | +6.1% |
| Sep 10 | Citi | $60 | +6.1% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 26, Cooper Companies averaged −0.4% across the last 5 years, rising in 1 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.6% | 2 of 5 |
| Next 10 trading days | −2.5% | 1 of 5 |
| Next 15 trading days | −0.4% | 3 of 5 |
| Next 20 trading days | −0.4% | 1 of 5 |
| Next 30 trading days | +0.8% | 4 of 5 |
For scale, COO’s typical 20-trading-day move in either direction is about 5.6%.
Cooper Companies’s market cap is $11.03B, with a P/E ratio of 19.3 and revenue of $4.24B over the last twelve months.
Coverage of Cooper Companies this week reads negative: 1 positive, 2 neutral and 13 negative headlines.
Cooper Companies’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 23.7% above |
| ABTAbbott Laboratories | Accumulation | 15.0% below |
| DHRDanaher | Distribution | 10.2% above |
| ISRGIntuitive Surgical | Neutral | 17.0% above |
| MDTMedtronic | Accumulation | 24.1% below |
| SYKStryker | Accumulation | 14.1% below |
A peer links to its own page where one exists.
Cooper Companies’s market cap is $11.03B at the Sep 28, 2026 close of $56.57, with 190.2M shares outstanding. The shares trade on a P/E ratio of 19.3.
The consensus analyst 12-month price target for Cooper Companies is $66.21, +17.0% from the last close. Of the 13 firms that rated the stock in the last 90 days, 4 rate it a buy, 9 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Cooper Companies is undervalued: the Sep 28, 2026 close of $56.57 is 6.6% below Gekko Fair Value of $60.55. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Cooper Companies is expected to report on Dec 3, 2026, after the market closes (65 days away). Analysts expect earnings of $1.08 per share on revenue of $1.07B. Cooper Companies beat the earnings estimate in 8 of its last 8 reports, moving 10.7% on average across the report.
Cooper Companies’s 52-week high is $89.83 and its 52-week low is $51.01; it closed at $56.57 on Sep 28, 2026, −15.4% over the past year. Over the last five years the shares peaked at $112.38 on Sep 16, 2024.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (gekkoindex, fair value, smart money and earnings risk) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.
Gekko flagged 2 unusual options signals in Cooper Companies over the last 30 days, with $820K of flagged premium in calls and $399K in puts. The latest, bullish flow, was on Sep 19, 2026 with $328K in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.